Cocrystal Pharma
Cocrystal Pharma is a clinical-stage biotechnology company focused on the discovery and development of novel antiviral therapeutics. Leveraging proprietary structure-based drug design technology, Cocrystal Pharma targets high-priority viral diseases, including influenza, norovirus, coronavirus, and hepatitis C. The company’s innovative approach aims to address significant unmet medical needs by developing effective, broad-spectrum antiviral drugs. Cocrystal Pharma’s pipeline includes multiple candidates in various stages of preclinical and clinical development, emphasizing safety, efficacy, and resistance profiles. Through strategic collaborations and a commitment to scientific excellence, Cocrystal Pharma strives to advance transformative antiviral therapies and improve global health outcomes.
